Gary Cline

Title: Gary Cline: Innovator in Hepatic Metabolism Assessment

Introduction

Gary Cline is a notable inventor based in New Haven, CT (US). He has made significant contributions to the field of hepatic metabolism through his innovative research and patented methodologies. His work focuses on non-invasive techniques that can provide valuable insights into metabolic processes.

Latest Patents

Cline holds a patent for a method titled "Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA)." This method allows for the non-invasive assessment of rates of hepatic mitochondrial oxidation and pyruvate carboxylase flux in subjects. The PINTA method utilizes a combined NMR and gas chromatography-mass spectrometry analysis of plasma following the infusion of [3-C]lactate and glucose tracer. This invention serves as a crucial tool for researchers examining altered hepatic mitochondrial metabolism and the effects of therapeutic interventions for conditions such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and type 2 diabetes (T2D).

Career Highlights

Gary Cline is affiliated with Yale University, where he continues to advance research in metabolic health. His work has garnered attention for its potential to improve understanding and treatment of metabolic disorders.

Collaborations

Cline has collaborated with esteemed colleagues, including Gerald I. Shulman and Rachel Jamison Perry. These partnerships have further enriched his research and contributed to the development of innovative methodologies in the field.

Conclusion

Gary Cline's contributions to the assessment of hepatic metabolism through his patented PINTA method highlight his role as a leading innovator in the field. His work not only enhances scientific understanding but also paves the way for improved therapeutic strategies for metabolic diseases.